日本-话题@MedSci - williamhill asia

#日本#

594篇内容 | 4979人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1294694, encodeId=c0a2129469466, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, objectTitle=Cancer Sci：T-VEC治疗日本晚期黑色素瘤患者的安全性和有效性-I期研究, objectType=article, longId=736665, objectId=88b3e36665f7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=88b3e36665f7, replyNumber=0, likeNumber=96, createdTime=2022-08-24, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=88b3e36665f7, moduleTitle=Cancer Sci：T-VEC治疗日本晚期黑色素瘤患者的安全性和有效性-I期研究, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=88b3e36665f7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1294693, encodeId=add11294693b3, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, objectTitle=Diabetol Int：日本2型糖尿病患者使用的各种口服降糖药中磺脲类药物比例的横断面研究, objectType=article, longId=736517, objectId=930ce36517e1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=930ce36517e1, replyNumber=0, likeNumber=66, createdTime=2022-08-23, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=930ce36517e1, moduleTitle=Diabetol Int：日本2型糖尿病患者使用的各种口服降糖药中磺脲类药物比例的横断面研究, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=930ce36517e1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1294692, encodeId=26891294692a0, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, objectTitle=5年生存率两倍于中国，同为胃癌高发国家，日本做了什么？, objectType=article, longId=735091, objectId=475be350918c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=475be350918c, replyNumber=0, likeNumber=77, createdTime=2022-08-08, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=475be350918c, moduleTitle=5年生存率两倍于中国，同为胃癌高发国家，日本做了什么？, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=475be350918c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1294691, encodeId=9937129469101, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, objectTitle=J Dermatol：日本脓疱性银屑病的临床特点, objectType=article, longId=732841, objectId=a265e32841ff, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a265e32841ff, replyNumber=0, likeNumber=0, createdTime=2022-07-21, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a265e32841ff, moduleTitle=J Dermatol：日本脓疱性银屑病的临床特点, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=a265e32841ff)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1294695, encodeId=ba9512946957a, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, objectTitle=日本临床肿瘤研究组肺癌外科系列研究之回顾与解读, objectType=article, longId=731616, objectId=b27fe3161625, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b27fe3161625, replyNumber=0, likeNumber=81, createdTime=2022-07-10, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b27fe3161625, moduleTitle=日本临床肿瘤研究组肺癌外科系列研究之回顾与解读, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=b27fe3161625)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1294690, encodeId=1ead1294690c2, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, objectTitle=盐野义新冠病毒特效药ensitrelvir拟提交国内上市申请，日本PMDA暂缓批准, objectType=article, longId=731414, objectId=8044e31414ef, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8044e31414ef, replyNumber=0, likeNumber=83, createdTime=2022-07-07, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8044e31414ef, moduleTitle=盐野义新冠病毒特效药ensitrelvir拟提交国内上市申请，日本PMDA暂缓批准, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=8044e31414ef)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1294689, encodeId=ef711294689ea, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, objectTitle=国家卫生健康委：昨日本土新增12+151（2022.7.1）, objectType=article, longId=731015, objectId=6f31e3101560, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6f31e3101560, replyNumber=0, likeNumber=90, createdTime=2022-07-03, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6f31e3101560, moduleTitle=国家卫生健康委：昨日本土新增12+151（2022.7.1）, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=6f31e3101560)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1294688, encodeId=dc3112946887f, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, objectTitle=上海连续2日本土零新增（2022.6.26）, objectType=article, longId=730523, objectId=97c1e3052326, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=97c1e3052326, replyNumber=0, likeNumber=113, createdTime=2022-06-28, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=97c1e3052326, moduleTitle=上海连续2日本土零新增（2022.6.26）, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=97c1e3052326)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1294687, encodeId=e9f8129468e7b, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, objectTitle=国家卫生健康委：昨日本土新增7+15 | 全国疫情最新消息（2022.6.25）, objectType=article, longId=730471, objectId=6d14e304716e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6d14e304716e, replyNumber=0, likeNumber=89, createdTime=2022-06-27, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6d14e304716e, moduleTitle=国家卫生健康委：昨日本土新增7+15 | 全国疫情最新消息（2022.6.25）, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=6d14e304716e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1294686, encodeId=0fdb1294686df, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, objectTitle=国家卫健委：昨日本土新增“18+26” | 全国疫情最新消息（2022.6.24）, objectType=article, longId=730395, objectId=ed66e303956d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ed66e303956d, replyNumber=0, likeNumber=72, createdTime=2022-06-26, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ed66e303956d, moduleTitle=国家卫健委：昨日本土新增“18+26” | 全国疫情最新消息（2022.6.24）, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=ed66e303956d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1294685, encodeId=fdfb129468589, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, objectTitle=苏爱康医药：日本核准DARVIAS®针剂135毫克（通用名：DARINAPARSIN/开发代码：SP-02）, objectType=article, longId=730161, objectId=38fee301618f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=38fee301618f, replyNumber=0, likeNumber=70, createdTime=2022-06-23, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=38fee301618f, moduleTitle=苏爱康医药：日本核准DARVIAS®针剂135毫克（通用名：DARINAPARSIN/开发代码：SP-02）, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=38fee301618f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1294684, encodeId=901a1294684d5, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, objectTitle=国家卫健委：昨日本土新增65+73 | 全国疫情最新消息（2022.6.11）, objectType=article, longId=729150, objectId=6882e291503d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6882e291503d, replyNumber=0, likeNumber=70, createdTime=2022-06-13, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6882e291503d, moduleTitle=国家卫健委：昨日本土新增65+73 | 全国疫情最新消息（2022.6.11）, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=6882e291503d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1294683, encodeId=9ee31294683a1, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, objectTitle=日本的真实世界研究和IIT, objectType=article, longId=728314, objectId=bcb3e283146c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bcb3e283146c, replyNumber=0, likeNumber=90, createdTime=2022-06-01, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bcb3e283146c, moduleTitle=日本的真实世界研究和IIT, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=bcb3e283146c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1294682, encodeId=500d12946823d, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, objectTitle=全球已报告348例不明病因儿童肝炎，韩国和日本也有发现, objectType=article, longId=726651, objectId=4b84e26651d3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4b84e26651d3, replyNumber=0, likeNumber=90, createdTime=2022-05-13, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4b84e26651d3, moduleTitle=全球已报告348例不明病因儿童肝炎，韩国和日本也有发现, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=4b84e26651d3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1294681, encodeId=22801294681dc, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, objectTitle=昨日本土新增353+5075 ｜全国疫情最新消息（2022.5.4）, objectType=article, longId=726127, objectId=8946e2612714, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8946e2612714, replyNumber=0, likeNumber=105, createdTime=2022-05-06, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8946e2612714, moduleTitle=昨日本土新增353+5075 ｜全国疫情最新消息（2022.5.4）, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=8946e2612714)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1294680, encodeId=ecad12946805e, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, objectTitle=上海昨日本土新增“260+4722”，新增本土死亡16例（2022.5.4）, objectType=article, longId=726100, objectId=f51ce2610036, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f51ce2610036, replyNumber=0, likeNumber=87, createdTime=2022-05-05, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f51ce2610036, moduleTitle=上海昨日本土新增“260+4722”，新增本土死亡16例（2022.5.4）, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=f51ce2610036)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1294679, encodeId=ac7012946e966, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, objectTitle=2022年5月4日简报：上海昨日本土新增260+4722例；台湾单日新增新冠肺炎确诊病例超2万；全球75%地方放开入境限制；香港新冠疫情持续趋缓放宽入境限制, objectType=article, longId=726097, objectId=2d68e2609724, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2d68e2609724, replyNumber=0, likeNumber=70, createdTime=2022-05-05, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2d68e2609724, moduleTitle=2022年5月4日简报：上海昨日本土新增260+4722例；台湾单日新增新冠肺炎确诊病例超2万；全球75%地方放开入境限制；香港新冠疫情持续趋缓放宽入境限制, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=2d68e2609724)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1294678, encodeId=30d312946e878, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, objectTitle=昨日本土新增368+5647｜全国疫情最新消息（2022.5.3）, objectType=article, longId=726058, objectId=e729e2605890, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e729e2605890, replyNumber=0, likeNumber=72, createdTime=2022-05-05, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e729e2605890, moduleTitle=昨日本土新增368+5647｜全国疫情最新消息（2022.5.3）, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=e729e2605890)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1294677, encodeId=d17112946e7b4, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, objectTitle=昨日本土新增846+6895 | 全国疫情最新消息（2022.5.2）, objectType=article, longId=726001, objectId=f0a2e26001e9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f0a2e26001e9, replyNumber=0, likeNumber=117, createdTime=2022-05-04, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f0a2e26001e9, moduleTitle=昨日本土新增846+6895 | 全国疫情最新消息（2022.5.2）, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=f0a2e26001e9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1294676, encodeId=c22412946e666, content=<a href='/topic/show?id=ca6e592189b' target=_blank style='color:#2F92EE;'>#日本#</a>, objectTitle=昨日本土新增916+7340 | 全国疫情最新消息（2022.5.1）, objectType=article, longId=725935, objectId=c031e259350a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c031e259350a, replyNumber=0, likeNumber=114, createdTime=2022-05-03, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c031e259350a, moduleTitle=昨日本土新增916+7340 | 全国疫情最新消息（2022.5.1）, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=c031e259350a)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] williamhill asia 话题小助手

日本

2020-05-29

chentianping (审核中...)

前往app查看评论内容

#日本#

Cancer Sci：T-VEC治疗日本晚期黑色素瘤患者的安全性和有效性-I期研究

2022-08-24

chentianping (审核中...)

前往app查看评论内容

#日本#

Diabetol Int：日本2型糖尿病患者使用的各种口服降糖药中磺脲类药物比例的横断面研究

2022-08-23

chentianping (审核中...)

前往app查看评论内容

#日本#

5年生存率两倍于中国，同为胃癌高发国家，日本做了什么？

2022-08-08

chentianping (审核中...)

前往app查看评论内容

#日本#

J Dermatol：日本脓疱性银屑病的临床特点

2022-07-21

chentianping (审核中...)

前往app查看评论内容

#日本#

日本临床肿瘤研究组肺癌外科系列研究之回顾与解读

2022-07-10

chentianping (审核中...)

前往app查看评论内容

#日本#

盐野义新冠病毒特效药ensitrelvir拟提交国内上市申请，日本PMDA暂缓批准

2022-07-07

chentianping (审核中...)

前往app查看评论内容

#日本#

国家卫生健康委：昨日本土新增12+151（2022.7.1）

2022-07-03

chentianping (审核中...)

前往app查看评论内容

#日本#

上海连续2日本土零新增（2022.6.26）

2022-06-28

chentianping (审核中...)

前往app查看评论内容

#日本#

国家卫生健康委：昨日本土新增7+15 | 全国疫情最新消息（2022.6.25）

2022-06-27

chentianping (审核中...)

前往app查看评论内容

#日本#

国家卫健委：昨日本土新增“18+26” | 全国疫情最新消息（2022.6.24）

2022-06-26

chentianping (审核中...)

前往app查看评论内容

#日本#

苏爱康医药：日本核准DARVIAS®针剂135毫克（通用名：DARINAPARSIN/开发代码：SP-02）

2022-06-23

chentianping (审核中...)

前往app查看评论内容

#日本#

国家卫健委：昨日本土新增65+73 | 全国疫情最新消息（2022.6.11）

2022-06-13

chentianping (审核中...)

前往app查看评论内容

#日本#

日本的真实世界研究和IIT

2022-06-01

chentianping (审核中...)

前往app查看评论内容

#日本#

全球已报告348例不明病因儿童肝炎，韩国和日本也有发现

2022-05-13

chentianping (审核中...)

前往app查看评论内容

#日本#

昨日本土新增353+5075 ｜全国疫情最新消息（2022.5.4）

2022-05-06

chentianping (审核中...)

前往app查看评论内容

#日本#

上海昨日本土新增“260+4722”，新增本土死亡16例（2022.5.4）

2022-05-05

chentianping (审核中...)

前往app查看评论内容

#日本#

2022年5月4日简报：上海昨日本土新增260+4722例；台湾单日新增新冠肺炎确诊病例超2万；全球75%地方放开入境限制；香港新冠疫情持续趋缓放宽入境限制

2022-05-05

chentianping (审核中...)

前往app查看评论内容

#日本#

昨日本土新增368+5647｜全国疫情最新消息（2022.5.3）

2022-05-05

chentianping (审核中...)

前往app查看评论内容

#日本#

昨日本土新增846+6895 | 全国疫情最新消息（2022.5.2）

2022-05-04

chentianping (审核中...)

前往app查看评论内容

#日本#

昨日本土新增916+7340 | 全国疫情最新消息（2022.5.1）

2022-05-03

科室
- - 订阅+
  - 更多科室
工具
服务